Multiple sclerosis severity score: Using disability and disease duration to rate disease severity

Neurology

Volumn 64, Issue 7, 2005, Pages 1144-1151

  Roxburgh, R H S R ^a,b   Seaman, S R ^c   Masterman, T ^d   Hensiek, A E ^a   Sawcer, S J ^a   Vukusic, S ^e   Achiti, I ^e   Confavreux, C ^e   Coustans, M ^f   Le Page, E ^f   Edan, G ^f   McDonnell, G V ^g   Hawkins, S ^g   Trojano, M ^h   Liguori, M ^h   Cocco, E ⁱ   Marrosu, M G ⁱ   Tesser, F ^j,k   Leone, M A ^j,k   Weber, A ^l   Zipp, F ^l   Miterski, B ^m   Epplen, J T ^m   Oturai, A ⁿ   Sørensen, P Soelberg ⁿ   Celius, E G ^o   Lara, N Téllez ^p   Montalban, X ^p   Villoslada, P ^q   Silva, A M ^r   Marta, M ^r   Leite, I ^r   Dubois, B ^s   Rubio, J ^t   Butzkueven, H ^t   Kilpatrick, T ^t,u   Mycko, M P ^v   Selmaj, K W ^v   Rio, M E ^w   Sa M ^w   Salemi, G ^x   Savettieri, G ^x   Hillert, J ^d   Compston, D A S ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e HÔPITAL NEUROLOGIQUE   (France)

^f PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^g ROYAL VICTORIA HOSPITAL   (United Kingdom)

^h UNIVERSITY OF BARI   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^k MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m RUHR UNIVERSITY BOCHUM   (Germany)

ⁿ Rigshospitalet   (Denmark)

^o ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^p Department of Neuropathology   (Spain)

^q UNIVERSITY CLINIC OF NAVARRA   (Spain)

^r HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^s UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^t WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^u Department of Civil and Environmental Engineering   (Australia)

^v MEDICAL UNIVERSITY OF LODZ   (Poland)

^w HOSPITAL DE SÃO JOÃO   (Portugal)

^x Department of Neuropsichiatry ^*  (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS SEVERITY SCORE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 20144387016     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000156155.19270.F8     Document Type: Article

References (13)

1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
2. Sawcer S, Maranian M, Setakis E, et al. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 2002;125:1337-1347.
3. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
4. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
5. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995;13:119-146.
6. Schmidt S, Barcellos LF, DeSombre K, et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet 2002;70:708-717.
7. Kantarci OH, de Andrade M, Weinshenker BG. Identifying disease modifying genes in multiple sclerosis, J Neuroimmunol 2002;123:144-159.
8. Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 1997;49:378-385.
9. Trojano M, Liguori M, Bosco Zimatore G, et al. Age-related disability in multiple sclerosis. Ann Neurol 2002;51:475-480.
10. Schindel F, Kwasny H. Stratified or multicentre analysis with extended Mantel-Haenszel statistics. Biometrical J 1991;33:755-762.
11. Fisher LD, van Belle G. Biostatistics. New York: Wiley, 1993.
12. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-882.
13. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001;124:962-973.